Showing 241 - 260 results of 804 for search '"Inflammatory bowel disease"', query time: 0.09s Refine Results
  1. 241

    Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine by Katarzyna Bąk-Drabik, Piotr Adamczyk, Justyna Duda-Wrońska, Dominika Dąbrowska-Piechota, Anna Jarzumbek, Jarosław Kwiecień

    Published 2021-01-01
    “…Thiopurines, such as azathioprine (AZA) and 6-mercaptopurine (6-MP), are immunomodulatory agents, used for the maintenance of remission in children with inflammatory bowel disease (IBD)—Crohn’s disease (CD) and ulcerative colitis (UC), as well as with autoimmunological hepatitis (AIH). …”
    Get full text
    Article
  2. 242

    Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year by Lars-Petter Jelsness-Jørgensen, Bjørn Moum, Tomm Bernklev

    Published 2011-01-01
    “…Disease-related worries are frequently reported in inflammatory bowel disease (IBD), but longitudinal assessments of these worries are scarce. …”
    Get full text
    Article
  3. 243

    Are there also negative effects of social support? A qualitative study of patients with inflammatory bowel disease by Alexander Palant, Wolfgang Himmel

    Published 2019-01-01
    “…By conducting a series of interviews with people who suffer from inflammatory bowel disease (IBD), we received the impression that social support in face-to-face or online communication could also be a source of stress and strain. …”
    Get full text
    Article
  4. 244

    Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease by Brian Bressler, Remo Panaccione, Richard N Fedorak, Ernest G Seidman

    Published 2015-01-01
    “…BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. …”
    Get full text
    Article
  5. 245

    The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives by Judith Bray, Aida Fernandes, Geoffrey C. Nguyen, Anthony R. Otley, Joan Heatherington, Jennifer Stretton, Natasha Bollegala, Eric I. Benchimol

    Published 2016-01-01
    “…Canada has one of the highest rates of inflammatory bowel disease (IBD) and the disease represents a significant health, social, and economic burden. …”
    Get full text
    Article
  6. 246

    Natural Killer Cell and Large Granular Lymphocyte Deficiency in the Gut of Children with Inflammatory Bowel Disease by F Hadziselimovic, LR Emmons, U Schaub

    Published 1990-01-01
    “…The occurrence of natural killer cells and large granular lymphocytes (LGL) within the epithelium of colonic mucosa in children with inflammatory bowel disease (IBD) was compared to normal controls. …”
    Get full text
    Article
  7. 247
  8. 248
  9. 249
  10. 250
  11. 251
  12. 252
  13. 253

    Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis by Yan Hu, Xiaoting Chen, Xiaojing Chen, Shuang Zhang, Tianyan Jiang, Jing Chang, Yanhong Gao

    Published 2017-01-01
    “…The purpose of this study was to evaluate the effect of bisphosphonates in improving bone mineral density (BMD) and decreasing the occurrence rate of fractures and adverse events in patients with inflammatory bowel disease (IBD). Methods. Randomized controlled trials (RCTs) which use bisphosphonates in IBD patients were identified in PubMed, MEDLINE database, EMBASE database, Web of Knowledge, and the Cochrane Databases between 1990 and June 2016. …”
    Get full text
    Article
  14. 254
  15. 255
  16. 256
  17. 257
  18. 258
  19. 259
  20. 260